Finance

Lists
4538:TYO
Fuso Pharmaceutical Industries Ltd
Â¥2,311.00
+1.63%
(+37.00) 1D
Aug 17, 11:06:20 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4538...
Open
Â¥2,274
High
Â¥2,311
Low
Â¥2,268
Mkt. cap
21.84B
Avg. vol.
15.32K
Volume
11.30K
Dividend
3.89%
Quarterly dividend
Â¥22
Ex-dividend date
Sep 29, 2026
P/E ratio
9.81
52-wk high
Â¥2,530
52-wk low
Â¥1,990
EPS
Â¥236
Shares outstanding
8.78M
No. of employees
1K
Open
Â¥2,274
High
Â¥2,311
Low
Â¥2,268
Mkt. cap
21.84B
Avg. vol.
15.32K
Volume
11.30K
Dividend
3.89%
Quarterly dividend
Â¥22
Ex-dividend date
Sep 29, 2026
P/E ratio
9.81
52-wk high
Â¥2,530
52-wk low
Â¥1,990
EPS
Â¥236
Shares outstanding
8.78M
No. of employees
1K
About Fuso Pharmaceutical Industries Ltd
CEO-
Employees1.37K
FoundedMar 25, 1937
Headquarters-
SectorPharmaceutical industry
Websitefuso-pharm.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
15.73B
17.04B
14.04B
16.05B
Cost of goods sold
11.70B
12.62B
10.57B
11.85B
Cost of revenue
11.70B
12.62B
10.57B
11.85B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.38B
3.30B
3.20B
3.22B
Operating expense
3.38B
3.30B
3.20B
3.22B
Total operating expenses
15.08B
15.91B
13.77B
15.07B
Operating income
650.00M
1.12B
272.00M
973.00M
Other non operating income
-110.00M
-24.00M
-40.00M
-134.00M
EBT including unusual items
456.00M
1.20B
132.00M
910.00M
EBT excluding unusual items
478.00M
1.08B
131.00M
828.00M
Income tax expense
87.00M
350.00M
-195.00M
268.00M
Effective tax rate
19.08%
29.09%
-147.73%
29.45%
Other operating expenses
-
-
-
-
Net income
369.00M
853.00M
327.00M
642.00M
Net profit margin
2.35%
5.01%
2.33%
4.00%
Earnings per share
-
-
-
-
Interest and investment income
14.00M
67.00M
1.00M
93.00M
Interest expense
-76.00M
-80.00M
-102.00M
-104.00M
Net interest expenses
-62.00M
-13.00M
-101.00M
-11.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.30B
-
926.50M
1.63B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps